<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01879579</url>
  </required_header>
  <id_info>
    <org_study_id>S12-03713</org_study_id>
    <secondary_id>UL1TR000038</secondary_id>
    <nct_id>NCT01879579</nct_id>
  </id_info>
  <brief_title>Mobile Insulin Titration Intervention</brief_title>
  <acronym>MITI</acronym>
  <official_title>The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New York City Health and Hospitals Corporation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this pilot study is to determine whether text message (and phone)
      communication can be effectively utilized to adjust long-acting insulin, compared to standard
      practice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current practice of insulin titration for diabetics requires multiple in-person clinic
      visits, during which a patient's long-acting insulin dose is adjusted until the optimal dose
      to control glycemia is reached. Finding this optimal dose can take weeks in an ideal setting,
      but often takes much longer in a busy urban clinic such as Bellevue Hospital Center. Relaying
      titration instructions to patients via phone and text message has the potential to decrease
      the titration timeline, thus reducing the number of clinic visits and the time it takes
      patients to reach their target blood glucose levels.

      For this pilot project, study staff will recruit patients who are initiating long-acting
      insulin treatment or initiating the titration of their existing long acting insulin treatment
      at Bellevue Hospital Center's Adult Primary Care Center. Patients who volunteer to enroll and
      provide informed consent will be randomized to one of two arms (MITI or current best practice
      arm) at the time of enrollment and stratified by whether the patient is initiating insulin
      treatment or initiating the titration of his/her existing insulin dose. The study staff will
      provide a cell phone (for temporary use) to any patients who are randomized to the MITI arm
      and don't own a personal cell phone (or whose personal cell phone is not able to receive the
      Sense Health text messages). Patients will use the cell phone free of cost to participate in
      the intervention (receive Sense Health text messages, send their fasting blood glucose
      levels, and speak with the diabetes nurse and study staff.)

      Patients in the MITI arm will receive automated text messages 5 weekdays per week, for up to
      12 weeks, from Sense Health. These text messages will request the patient's fasting blood
      glucose level. The patient will reply with his/her fasting blood glucose value, which will be
      logged in password-protected accounts on www.sensehealth.com. The clinic's diabetes nurses
      will check each patient's fasting blood glucose level on www.sensehealth.com each weekday and
      call any patient with fasting blood glucose values &lt; 80 mg/dL and &gt; 400 mg/dL. Each Thursday,
      patients will receive a phone call from a nurse, who will adjust the patient's insulin dose
      according to the study titration protocol. Each patient will continue to receive daily text
      messages and weekly phone calls until the first of three events occur: the patient reaches
      his/her optimal insulin dose for achieving glycemic control, 12 weeks elapse, or the patient
      withdraws from the study.

      Patients in the current best practice arm (CBP) will attend scheduled clinic appointments
      during which a provider will review the patient's fasting blood glucose log and titrate the
      insulin dose according to current best practice.

      Patients in both arms will continue receiving routine care, including HbA1c values every 3
      months and other routine labs and measures as per standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Subjects Who Reach Optimal Long-acting Insulin Dose</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Reach Optimal Long-acting Insulin Dose</measure>
    <time_frame>12 weeks</time_frame>
    <description>The time it takes a patient to reach his/her optimal long-acting insulin dose will be measured for both study arms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>baseline, 12 weeks (approximately 3 months)</time_frame>
    <description>Change in hemoglobin A1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline Treatment Satisfaction</measure>
    <time_frame>baseline</time_frame>
    <description>The Diabetes Treatment Satisfaction Questionnaire standard (DTSQs) will be used to measure the patient's satisfaction with diabetes treatment received prior to study participation. Scores on questionnaire range from 0 to 6: 0 = very dissatisfied, 6 = very satisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Satisfaction After Initiation of Insulin Titration</measure>
    <time_frame>12 weeks (approximately 3 months)</time_frame>
    <description>The Diabetes Treatment Satisfaction Questionnaire standard (DTSQs) will be used to measure the patient's satisfaction with diabetes treatment received since initiation of long-acting insulin titration. Scores on questionnaire range from 0 to 6: 0 = very dissatisfied, 6 = very satisfied.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Treatment Satisfaction</measure>
    <time_frame>12 weeks (approximately 3 months)</time_frame>
    <description>The Diabetes Treatment Satisfaction Questionnaire change (DTSQc) will be used to measure the change in the patient's satisfaction with his/her diabetes treatment since initiation of long-acting insulin titration. Scores on questionnaire range from -3 to +3: -3 = much less satisfied now, +3 = much more satisfied now.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hypoglycemia</measure>
    <time_frame>12 weeks</time_frame>
    <description>The number of instances of hypoglycemia as indicated by fasting blood glucose levels or symptoms reported by patients in both study arms.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Percentage of Text Message Responses</measure>
    <time_frame>12 weeks</time_frame>
    <description>The number of text message replies from participants compared to the total number of text messages sent to participants (asking for blood glucose values). This outcome is given as a percent.</description>
  </other_outcome>
  <other_outcome>
    <measure>Percentage of Successful Phone Calls</measure>
    <time_frame>12 weeks</time_frame>
    <description>The number of successful insulin titration phone calls compared to the total number of insulin titration phone calls assigned to the nurse. Successful phone calls are defined as when the nurse was able to reach the participant with one call attempt, two call attempts, or by voicemail. This outcome is given as a percent.</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient Healthcare Utilization</measure>
    <time_frame>12 weeks</time_frame>
    <description>The number of medication refill, emergency department, and walk-in clinic visits at Bellevue Hospital (non-insulin titration visits).</description>
  </other_outcome>
  <other_outcome>
    <measure>Costs - Provider Time Spent on Insulin Titration Visits</measure>
    <time_frame>12 weeks</time_frame>
    <description>Provider time spent on insulin titration visits by phone compared to insulin titration visits in the clinic.</description>
  </other_outcome>
  <other_outcome>
    <measure>Costs - Titration Visit Information</measure>
    <time_frame>12 weeks</time_frame>
    <description>The number of insulin titration visits (whether by phone or in the clinic).</description>
  </other_outcome>
  <other_outcome>
    <measure>Costs - Patient Travel Time</measure>
    <time_frame>12 weeks</time_frame>
    <description>The time it took patients to travel to Bellevue Hospital, reported by patients in both study arms at baseline and at any subsequent clinic visits.</description>
  </other_outcome>
  <other_outcome>
    <measure>Costs - Co-pays</measure>
    <time_frame>baseline</time_frame>
    <description>At baseline, participants in both study arms (MITI and CBP) reported whether they had to pay co-pays for clinic visits at Bellevue Hospital.</description>
  </other_outcome>
  <other_outcome>
    <measure>Qualitative Patient Satisfaction Interview</measure>
    <time_frame>After patient reaches optimal insulin dose or at 12 weeks</time_frame>
    <description>The study staff will interview MITI arm patients, using free-response questions, to assess their satisfaction with the intervention. The interviews will take place in person or over the phone at the patient's convenience, after the patient has reached his/her optimal insulin dose. If the patient does not reach optimal insulin dose, the interview will take place at approximately 12 weeks.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Mobile Insulin Titration Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Current Best Practice</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mobile Insulin Titration Intervention</intervention_name>
    <description>Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
    <arm_group_label>Mobile Insulin Titration Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Initiating long-acting insulin treatment or initiating the titration of long-acting
             insulin treatment

          -  Speaks English or Spanish

          -  Hemoglobin A1c &gt; or = 8%

          -  Able and willing to inject insulin

          -  Able and willing to provide informed consent

        Exclusion Criteria:

          -  Short-acting insulin treatment

          -  Systemic glucocorticoids

          -  Sustained elevated serum creatinine &gt; or = 1.5 mg/dL for men and &gt; or = 1.4 mg/dL for
             women

          -  Hypoglycemia unawareness

          -  Type 1 diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Natalie Levy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Adult Primary Care Clinic, Bellevue Hospital Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003 Nov;26(11):3080-6.</citation>
    <PMID>14578243</PMID>
  </reference>
  <reference>
    <citation>Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R; ATLANTUS Study Group. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care. 2005 Jun;28(6):1282-8.</citation>
    <PMID>15920040</PMID>
  </reference>
  <reference>
    <citation>Davies M, Lavalle-González F, Storms F, Gomis R; AT.LANTUS Study Group. Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial. Diabetes Obes Metab. 2008 May;10(5):387-99. doi: 10.1111/j.1463-1326.2008.00873.x. Epub 2008 Mar 18.</citation>
    <PMID>18355327</PMID>
  </reference>
  <reference>
    <citation>Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study. Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.</citation>
    <PMID>19515182</PMID>
  </reference>
  <reference>
    <citation>Arora S, Peters AL, Agy C, Menchine M. A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program. Diabetes Technol Ther. 2012 Jun;14(6):492-6. doi: 10.1089/dia.2011.0252. Epub 2012 Apr 23.</citation>
    <PMID>22524591</PMID>
  </reference>
  <reference>
    <citation>Walker EA, Shmukler C, Ullman R, Blanco E, Scollan-Koliopoulus M, Cohen HW. Results of a successful telephonic intervention to improve diabetes control in urban adults: a randomized trial. Diabetes Care. 2011 Jan;34(1):2-7. doi: 10.2337/dc10-1005.</citation>
    <PMID>21193619</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 13, 2013</study_first_submitted>
  <study_first_submitted_qc>June 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2013</study_first_posted>
  <results_first_submitted>August 11, 2015</results_first_submitted>
  <results_first_submitted_qc>September 15, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 12, 2015</results_first_posted>
  <last_update_submitted>September 15, 2015</last_update_submitted>
  <last_update_submitted_qc>September 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York University School of Medicine</investigator_affiliation>
    <investigator_full_name>Natalie Levy</investigator_full_name>
    <investigator_title>Assistant Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Insulin</keyword>
  <keyword>Telemedicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Mobile Insulin Titration Intervention</title>
          <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
        </group>
        <group group_id="P2">
          <title>Current Best Practice</title>
          <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Phone incompatible with texting platform</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not enroll in texting platform</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not initiate insulin treatment</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Phenotypic type 1 diabetes</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinued insulin - possible allergy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Mobile Insulin Titration Intervention</title>
          <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
        </group>
        <group group_id="B2">
          <title>Current Best Practice</title>
          <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48.48" spread="11.22"/>
                    <measurement group_id="B2" value="44.61" spread="9.97"/>
                    <measurement group_id="B3" value="46.70" spread="10.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Subjects Who Reach Optimal Long-acting Insulin Dose</title>
        <time_frame>12 weeks</time_frame>
        <population>No primary outcome data available for one participant in Current Best Practice arm who discontinued insulin early due to a mild possible allergy.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Subjects Who Reach Optimal Long-acting Insulin Dose</title>
          <population>No primary outcome data available for one participant in Current Best Practice arm who discontinued insulin early due to a mild possible allergy.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88"/>
                    <measurement group_id="O2" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Reach Optimal Long-acting Insulin Dose</title>
        <description>The time it takes a patient to reach his/her optimal long-acting insulin dose will be measured for both study arms.</description>
        <time_frame>12 weeks</time_frame>
        <population>Participants who reached optimal long-acting insulin dose.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Reach Optimal Long-acting Insulin Dose</title>
          <description>The time it takes a patient to reach his/her optimal long-acting insulin dose will be measured for both study arms.</description>
          <population>Participants who reached optimal long-acting insulin dose.</population>
          <units>weeks</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.00" lower_limit="1.29" upper_limit="4.86"/>
                    <measurement group_id="O2" value="7.07" lower_limit="2.96" upper_limit="9.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.007</p_value>
            <method>Interval-censoring survival analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hemoglobin A1c</title>
        <description>Change in hemoglobin A1c</description>
        <time_frame>baseline, 12 weeks (approximately 3 months)</time_frame>
        <population>All participants with hemoglobin A1c measurements recorded at baseline and 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Hemoglobin A1c</title>
          <description>Change in hemoglobin A1c</description>
          <population>All participants with hemoglobin A1c measurements recorded at baseline and 12 weeks.</population>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.90" spread="2.64"/>
                    <measurement group_id="O2" value="-1.81" spread="2.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.99</p_value>
            <method>Wilcoxon rank-sum test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Baseline Treatment Satisfaction</title>
        <description>The Diabetes Treatment Satisfaction Questionnaire standard (DTSQs) will be used to measure the patient’s satisfaction with diabetes treatment received prior to study participation. Scores on questionnaire range from 0 to 6: 0 = very dissatisfied, 6 = very satisfied.</description>
        <time_frame>baseline</time_frame>
        <population>All participants who completed the treatment satisfaction questionnaire at baseline.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Baseline Treatment Satisfaction</title>
          <description>The Diabetes Treatment Satisfaction Questionnaire standard (DTSQs) will be used to measure the patient’s satisfaction with diabetes treatment received prior to study participation. Scores on questionnaire range from 0 to 6: 0 = very dissatisfied, 6 = very satisfied.</description>
          <population>All participants who completed the treatment satisfaction questionnaire at baseline.</population>
          <units>score on satisfaction scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.99" spread="1.14"/>
                    <measurement group_id="O2" value="5.20" spread="0.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.78</p_value>
            <method>Wilcoxon rank-sum test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Satisfaction After Initiation of Insulin Titration</title>
        <description>The Diabetes Treatment Satisfaction Questionnaire standard (DTSQs) will be used to measure the patient's satisfaction with diabetes treatment received since initiation of long-acting insulin titration. Scores on questionnaire range from 0 to 6: 0 = very dissatisfied, 6 = very satisfied.</description>
        <time_frame>12 weeks (approximately 3 months)</time_frame>
        <population>All participants who completed the treatment satisfaction questionnaire at 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Satisfaction After Initiation of Insulin Titration</title>
          <description>The Diabetes Treatment Satisfaction Questionnaire standard (DTSQs) will be used to measure the patient's satisfaction with diabetes treatment received since initiation of long-acting insulin titration. Scores on questionnaire range from 0 to 6: 0 = very dissatisfied, 6 = very satisfied.</description>
          <population>All participants who completed the treatment satisfaction questionnaire at 12 weeks.</population>
          <units>score on satisfaction scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.74" spread="0.54"/>
                    <measurement group_id="O2" value="5.53" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.04</p_value>
            <method>Wilcoxon rank-sum test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Treatment Satisfaction</title>
        <description>The Diabetes Treatment Satisfaction Questionnaire change (DTSQc) will be used to measure the change in the patient's satisfaction with his/her diabetes treatment since initiation of long-acting insulin titration. Scores on questionnaire range from -3 to +3: -3 = much less satisfied now, +3 = much more satisfied now.</description>
        <time_frame>12 weeks (approximately 3 months)</time_frame>
        <population>All participants who completed the treatment satisfaction questionnaire at 12 weeks.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Treatment Satisfaction</title>
          <description>The Diabetes Treatment Satisfaction Questionnaire change (DTSQc) will be used to measure the change in the patient's satisfaction with his/her diabetes treatment since initiation of long-acting insulin titration. Scores on questionnaire range from -3 to +3: -3 = much less satisfied now, +3 = much more satisfied now.</description>
          <population>All participants who completed the treatment satisfaction questionnaire at 12 weeks.</population>
          <units>score on satisfaction scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.71" spread="0.71"/>
                    <measurement group_id="O2" value="2.42" spread="0.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>Wilcoxon rank-sum test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Hypoglycemia</title>
        <description>The number of instances of hypoglycemia as indicated by fasting blood glucose levels or symptoms reported by patients in both study arms.</description>
        <time_frame>12 weeks</time_frame>
        <population>This outcome was analyzed for participants who completed the allocated intervention (and the participant who discontinued insulin early due to a mild possible allergy). Five participants reported hypoglycemia: 3 in the MITI arm and 2 in the CBP arm. All cases were mild.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Hypoglycemia</title>
          <description>The number of instances of hypoglycemia as indicated by fasting blood glucose levels or symptoms reported by patients in both study arms.</description>
          <population>This outcome was analyzed for participants who completed the allocated intervention (and the participant who discontinued insulin early due to a mild possible allergy). Five participants reported hypoglycemia: 3 in the MITI arm and 2 in the CBP arm. All cases were mild.</population>
          <units>instances of hypoglycemia</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Text Message Responses</title>
        <description>The number of text message replies from participants compared to the total number of text messages sent to participants (asking for blood glucose values). This outcome is given as a percent.</description>
        <time_frame>12 weeks</time_frame>
        <population>Participants who completed the allocated intervention.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Text Message Responses</title>
          <description>The number of text message replies from participants compared to the total number of text messages sent to participants (asking for blood glucose values). This outcome is given as a percent.</description>
          <population>Participants who completed the allocated intervention.</population>
          <units>percentage of text messages</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>text messages sent to participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="498"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Percentage of Successful Phone Calls</title>
        <description>The number of successful insulin titration phone calls compared to the total number of insulin titration phone calls assigned to the nurse. Successful phone calls are defined as when the nurse was able to reach the participant with one call attempt, two call attempts, or by voicemail. This outcome is given as a percent.</description>
        <time_frame>12 weeks</time_frame>
        <population>Participants who completed the allocated intervention.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Successful Phone Calls</title>
          <description>The number of successful insulin titration phone calls compared to the total number of insulin titration phone calls assigned to the nurse. Successful phone calls are defined as when the nurse was able to reach the participant with one call attempt, two call attempts, or by voicemail. This outcome is given as a percent.</description>
          <population>Participants who completed the allocated intervention.</population>
          <units>percentage of phone calls</units>
          <param>Number</param>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>titration phone calls assigned to nurse</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="99"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Patient Healthcare Utilization</title>
        <description>The number of medication refill, emergency department, and walk-in clinic visits at Bellevue Hospital (non-insulin titration visits).</description>
        <time_frame>12 weeks</time_frame>
        <population>All participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Healthcare Utilization</title>
          <description>The number of medication refill, emergency department, and walk-in clinic visits at Bellevue Hospital (non-insulin titration visits).</description>
          <population>All participants.</population>
          <units>hospital visits</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Costs - Provider Time Spent on Insulin Titration Visits</title>
        <description>Provider time spent on insulin titration visits by phone compared to insulin titration visits in the clinic.</description>
        <time_frame>12 weeks</time_frame>
        <population>Insulin titration visits with a duration recorded.</population>
        <group_list>
          <group group_id="O1">
            <title>Insulin Titration Visits by Phone</title>
            <description>Insulin titration visits that occurred over the phone in both study arms (MITI and CBP arms).</description>
          </group>
          <group group_id="O2">
            <title>Insulin Titration Visits in the Clinic</title>
            <description>Insulin titration visits that occurred in the clinic in both study arms (MITI and CBP arms).</description>
          </group>
        </group_list>
        <measure>
          <title>Costs - Provider Time Spent on Insulin Titration Visits</title>
          <description>Provider time spent on insulin titration visits by phone compared to insulin titration visits in the clinic.</description>
          <population>Insulin titration visits with a duration recorded.</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>type of insulin titration visit</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="97"/>
                <count group_id="O2" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="3" upper_limit="10"/>
                    <measurement group_id="O2" value="30" lower_limit="20" upper_limit="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <method>Generalized estimating equation modeling</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Costs - Titration Visit Information</title>
        <description>The number of insulin titration visits (whether by phone or in the clinic).</description>
        <time_frame>12 weeks</time_frame>
        <population>Participants who completed the allocated intervention (and the participant who discontinued insulin early).</population>
        <group_list>
          <group group_id="O1">
            <title>Mobile Insulin Titration Intervention</title>
            <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
          </group>
          <group group_id="O2">
            <title>Current Best Practice</title>
            <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
          </group>
        </group_list>
        <measure>
          <title>Costs - Titration Visit Information</title>
          <description>The number of insulin titration visits (whether by phone or in the clinic).</description>
          <population>Participants who completed the allocated intervention (and the participant who discontinued insulin early).</population>
          <units>insulin titration visits</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.003</p_value>
            <method>Wilcoxon rank-sum test</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Costs - Patient Travel Time</title>
        <description>The time it took patients to travel to Bellevue Hospital, reported by patients in both study arms at baseline and at any subsequent clinic visits.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Participants</title>
            <description>Participants in both study arms (MITI and CBP).</description>
          </group>
        </group_list>
        <measure>
          <title>Costs - Patient Travel Time</title>
          <description>The time it took patients to travel to Bellevue Hospital, reported by patients in both study arms at baseline and at any subsequent clinic visits.</description>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="30" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Costs - Co-pays</title>
        <description>At baseline, participants in both study arms (MITI and CBP) reported whether they had to pay co-pays for clinic visits at Bellevue Hospital.</description>
        <time_frame>baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Participants</title>
            <description>Participants in both study arms (MITI and CBP).</description>
          </group>
        </group_list>
        <measure>
          <title>Costs - Co-pays</title>
          <description>At baseline, participants in both study arms (MITI and CBP) reported whether they had to pay co-pays for clinic visits at Bellevue Hospital.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Qualitative Patient Satisfaction Interview</title>
        <description>The study staff will interview MITI arm patients, using free-response questions, to assess their satisfaction with the intervention. The interviews will take place in person or over the phone at the patient's convenience, after the patient has reached his/her optimal insulin dose. If the patient does not reach optimal insulin dose, the interview will take place at approximately 12 weeks.</description>
        <time_frame>After patient reaches optimal insulin dose or at 12 weeks</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>We were able to assess serious adverse events for participants who completed the allocated intervention (and the participant who discontinued insulin early due to a mild possible allergy). No serious adverse events were found.</desc>
      <group_list>
        <group group_id="E1">
          <title>Mobile Insulin Titration Intervention</title>
          <description>Mobile Insulin Titration Intervention (MITI) arm patients will relay their fasting blood glucose levels to the study staff via text message. The patient will receive insulin titration instructions through a weekly phone call with a diabetes nurse.
Mobile Insulin Titration Intervention: Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.</description>
        </group>
        <group group_id="E2">
          <title>Current Best Practice</title>
          <description>Current Best Practice (CBP) arm patients will be treated according to the current best practice of insulin titration. They will attend scheduled clinic visits during which the provider will review their blood glucose logs and provide insulin titration instructions.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>mild hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="27"/>
              </event>
              <event>
                <sub_title>mild possible allergy to insulin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Natalie Levy</name_or_title>
      <organization>New York University School of Medicine</organization>
      <phone>2122638924</phone>
      <email>Natalie.Levy@nyumc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

